Clinical Biomarker and Immunogenicity Testing Services

PBI provides biomarker laboratory services designed to support the needs of biotherapeutic development. These services include developing, validating and performing methods for immunogenicity testing and novel biomarker assays, including technology transfers.

Pacific Biomarkers, Inc. offers:

Novel Biomarker Assay Development

• Immunogenicity Testing Services
• Cell Based Assays
• Multiplexing
• Pharmacokinetic (PK) Assays
• Technical Collaboration
• Protocol Design
• Since 1989, PBI has partnered with the Pharmaceutical, Biotech, and Diagnostic Manufacturing Industries to provide biomarker laboratory services.

Immunogenicity Testing

• Anti-Drug-Antibodies
• Cell Based Assays
• Clinical Biomarker Services
• Novel Biomarker Assay Development
• Technology Transfer
• Commercial Assay Optimization

Analytical Platforms

• ELISA
• Gradient Gel Electrophoresis (GGE)
• HPLC/UHPLC
• LC – MS/MS
• Luminex™
• Meso Scale Discovery (MSD®)
• RIA
• Roche Elecsys®
• Roche Modular P®
• Siemens Immulite®
• Ultracentrifugation
• In-Cell Western

Regulatory Status

• CAP
• CDC-NHLBI LSP
• CLIA
• GLP
• NGSP
• N.Y. State DOH